Pleno, a clinical and multi-omics diagnostics company that is revolutionizing biological target detection, today announced the appointment of Dr. Vik Vaz M.D. as its new chief executive officer and to serve on its Board of Directors, effective immediately. Dr. Vaz is a dynamic global leader with a combination of clinical expertise, strategic insight, and commercial experience in the life sciences and medical technology sectors. Dr. Vaz will lead Pleno's next phase of growth as the company prepares to scale its commercial operations with the help of its new $25 million Series B funding. Key investors Deerfield Management, Foresite Capital and Medical Excellence Capital remain committed to supporting the next phase of the company's growth strategy.

Pleno is an early-stage San Diego startup company developing the RAPTOR™ multi-omic instrument platform to revolutionize biological target detection and enable a broad array of life science applications. The company makes complex multi-omic known-target detection accessible and affordable to everyone through the innovative use of its Hypercoding™ technology which simplifies the entire process and enables unprecedented improvements in performance, cost and scale.